ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "death"

  • Abstract Number: 1263 • 2013 ACR/ARHP Annual Meeting

    Childhood-Onset Systemic Lupus Erythematosus In Ontario:  Long Term Outcomes In a Population-Based Cohort With Universal Health Care Coverage

    Deborah M. Levy1, Nadia Gunraj2, Janet E. Pope3, J. Carter Thorne4, Wesley Fidler5, Peter B. Dent6, Johannes Roth7, Roberta A. Berard8, Murray Berall9, Astrid Guttmann10 and Earl D. Silverman11, 1Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Medicine/Rheumatology, St. Joseph's Health Care, University of Western Ontario, London, ON, Canada, 4Southlake Regional Health Centre, Newmarket, ON, Canada, 5Rheumatology, St. Joseph's Hospital, Thunder Bay, ON, Canada, 6McMaster University, Hamilton, ON, Canada, 7University of Ottawa, Ottawa, ON, Canada, 8Children's Hospital of Western Ontario, London, ON, Canada, 9Nephrology, Humber River Regional Hospital, Toronto, ON, Canada, 10Pediatrics, Institute for Clinical Evaluative Sciences, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 11Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Little is known about the long-term morbidity and mortality of childhood-onset SLE (cSLE) after transition to adult care; however, linking clinical data to administrative…
  • Abstract Number: 1035 • 2013 ACR/ARHP Annual Meeting

    Psoriatic Arthritis and Mortality – a Nationwide Study

    Thorvardur Jon Love1,2, Thor Aspelund3, Alexis Ogdie4, Joel M. Gelfand5, Hyon K. Choi6, Vilmundur Gudnason3 and Bjorn Gudbjornsson2, 1Landspitali University Hospital, Reykjavik, Iceland, 2Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 3The Icelandic Heart Association, Kopavogur, Iceland, 4Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 5University of Pennsylvania., Philadelphia, PA, 6Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Psoriatic arthritis is an inflammatory arthritis that causes significant morbidity. While a study from a single research clinic in Canada published in the 1990´s…
  • Abstract Number: 413 • 2013 ACR/ARHP Annual Meeting

    A Multiple Cause-Of-Death Study In Rheumatoid Arthritis

    Frederico A. G. Pinheiro1, Deborah C. C. Souza1 and Emilia I. Sato2, 1Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 2Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil

    Background/Purpose: Rheumatoid arthritis (RA) is the most common chronic inflammatory arthritis and has a high standardized mortality ratio when compared to general population. One of…
  • Abstract Number: 100 • 2013 ACR/ARHP Annual Meeting

    Myocardial Infarction and Mortality after Joint Surgery in Patients with Rheumatoid Arthritis Compared with the General Population

    Joanne Tropea1, Mark Tacey2, Megan Bohensky2, Caroline Brand2, Ian Wicks3 and Sharon Van Doornum2, 1Melbourne EpiCentre, Royal Melbourne Hospital, Melbourne, Australia, 2Melbourne EpiCentre, The University of Melbourne, Melbourne, Australia, 3Rheumatology Unit, Royal Melbourne Hospital, Melbourne, Australia

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased risk of myocardial infarction (MI) and post-MI fatality compared with the general population.  In a previous…
  • Abstract Number: 307 • 2012 ACR/ARHP Annual Meeting

    Risk Factors for Poor Outcomes in Hospitalized Patients with Pediatric Systemic Lupus Erythematosus

    Mary Beth F. Son1, Victor M. Johnson2, Mindy S. Lo3 and Karen H. Costenbader4, 1Division of Rheumatology and Immunology, University Children's Medical Institute, Singapore, Singapore, 2Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital Boston, Boston, MA, 3Division of Immunology, Boston Children's Hospital, Boston, MA, 4Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose:  Disparities in care among adults with SLE are well documented.  We investigated associations of demographic factors and volume of annual inpatient hospital admissions with…
  • Abstract Number: 936 • 2012 ACR/ARHP Annual Meeting

    Autoimmune Diseases: Declining Mortality Between 1999 and 2008 However Continuing to be a Leading Cause of Death in Children-A 10-Year Retrospective Review

    Eric Y. Yen1 and Deborah K. McCurdy2, 1Pediatrics/Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, 2Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA

    Background/Purpose: Autoimmune diseases are chronic illnesses that cause significant and chronic disability in children and may lead to death. Using mortality data from 1995, Walsh…
  • Abstract Number: 1466 • 2012 ACR/ARHP Annual Meeting

    Patients with Systemic Sclerosis Are Dying of Non-Systemic Sclerosis Related Causes, However Interstitial Lung Disease Remains the Predominant Systemic Sclerosis Related Cause of Death

    Rebecca L. Batten and Bridget Griffiths, Rheumatology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom

    Interstitial Lung Disease Remains the leading Cause of Death in Patients with Systemic Sclerosis, Despite Aggressive Treatment with CyclophosphamideBackground/Purpose: Studies suggest that despite aggressive treatment…
  • Abstract Number: 2315 • 2012 ACR/ARHP Annual Meeting

    Foxp3+ Treg Cells Decreased in Overexpression of T-Bet in PD-1 Deficient Mice

    Masahiro Tahara1, Yuya Kondo1, Hiroto Tsuboi2, Satoru Takahashi3, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 2Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 3Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba city, Ibaraki, Japan

    Background/Purpose: Programmed cell Death-1 (PD-1) plays an important role in peripheral T cell tolerance, therefore PD-1 deficient (PD-1 KO) mice develop strain-specific autoimmune phenotypes. C57BL/6…
  • Abstract Number: 2685 • 2012 ACR/ARHP Annual Meeting

    Overall and Cause Specific Mortality in Patients with Systemic Lupus Erythematosus. A Meta-Analysis of Observational Studies

    Marko Yurkovich1, Kateryna Vostretsova2 and J. Antonio Avina-Zubieta3, 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada

    Background/Purpose:  Systemic lupus erythematosus (SLE), is a chronic autoimmune condition. It has the potential to affect any organ system and can be associated with severe…
  • « Previous Page
  • 1
  • 2
  • 3
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences